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 Human mesenchymal stem/stromal cells (hMSC) are 
currently being studied in a number of clinical applica-
tions, for example, to improve the engraftment of he-
matopoietic stem cell transplant, to promote myocardial 
repair, and to control immunological responses in graft 
versus host diseases, autoimmune diseases, and solid or-
gan transplantations ( 1–5 ). In addition to being immuno-
logically privileged, these cells can modulate both innate 
and adaptive immune responses in vitro and in vivo. hMSCs 
have been shown to be able to inhibit T-cell proliferation, 
inhibit dendritic cell maturation ( 6 ), recruit regulatory 
T-cells ( 7, 8 ), and modulate B-cell functions ( 9 ). The mecha-
nisms by which these cells exert their immune modulatory 
functions are still unclear, but it is likely that both direct 
cell-cell contacts and the secretion of soluble factors are 
needed. Several cytokines, growth factors, enzymes, and 
lipid mediators, such as transforming growth factor   1, the 
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sions. As it is well established that membrane glycerophos-
pholipids (GPL) provide precursors for signaling lipids 
that modulate cellular functions, we studied the effect of 
the donor’s age and cell doublings on the GPL profi le of 
human bone marrow MSC (hBMSC). The hBMSCs, which 
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clear compositional changes during expansion seen at 
the level of lipid classes, lipid species, and acyl chains. 
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20:4n-6-containing species of phosphatidylcholine and 
phosphatidylethanolamine accumulated while the species 
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determine the expression of genes related to lipid metabo-
lism and immunomodulation, and gain a better understand-
ing of the possible relations of cell lipidome changes and 
functionality. Knowledge of the connections of lipid alter-
ations during expansion and their effect on the immuno-
suppressive capacity of the therapeutic cells may have a 
profound infl uence on clinical cell expansion protocols. 
 MATERIALS AND METHODS 
 Ethics and bone marrow donors 
 All patient protocols were approved by the Ethical Committee 
of Northern Ostrobothnia Hospital District or Ethical Committee 
of Hospital District of Helsinki and Uusimaa. The hBMSCs were 
obtained from bone marrow aspirates taken from the iliac crest or 
upper femur methaphysis of adult patients after written informed 
consent. The hBMSCs from donors of different ages (anonymous 
coding) were isolated as previously described ( 30, 31 ). 
 Cell culture of hBMSC 
 The cells were cultured in minimum essential   -medium 
(  MEM) supplemented with 20 mM HEPES, 10% fetal bovine 
serum (FBS), 2 mM L-glutamine, 100 units/ml penicillin, and 
100   g/ml streptomycin (all from Gibco, Invitrogen, Paisley, 
UK). The same serum lot was used throughout the study. The 
medium was renewed twice a week, the cells were harvested when 
70–80% confl uent and plated at a density of 1,000 cells/cm 2 . 
Population doublings for every passage were calculated using the 
formula NH = 2 PD × N1, where NH is the number of cells har-
vested and N1 is the number of cells plated. For lipid analysis, the 
cells were washed with ice-cold PBS scraped on ice pelleted in 
silylated vials and stored at   70°C for later use. The expression 
of surface antigens CD13, CD14, CD19, CD29, CD34, CD44, 
CD45, CD49e, CD73, CD90, CD105, CD106, CD166, CD271, 
HLA-ABC, and HLA-DR were analyzed by fl ow cytometry (FAC-
SAria, Becton Dickinson, San Jose, CA, and FlowJo 7.6.1 software, 
Treestar, Asland, OR) (supplementary Table I). 
 Phospholipid mass spectrometry and fatty acid gas 
chromatography 
 Total lipids of the hBMSCs were extracted according to Folch 
et al. ( 32 ), spiked with internal standards, and dissolved in chlo-
roform/methanol 1:2 for direct infusion experiments. Several 
internal standards were used to correct for the effects of the 
polar head group and acyl chain length on the instrument re-
sponse according to previously reported procedures ( 33–35 ). 
Just prior to the mass spectrometry analysis, 1% NH 4 OH was 
added, and the lipid extracts with the internal standards were 
infused to the electrospray source of a Quattro Micro triple qua-
drupole mass spectrometer (Micromass, Manchester, UK) at the 
fl ow rate of 8   l/min. The collision energy of the instrument was 
set to 25–65 eV, and negative and positive ion modes were used. 
Argon was used as the collision gas. The PC and lysoPC (precur-
sor of 184), PE (neutral loss of 141), PS (neutral loss of 87), and 
PI (precursor of 241) species were selectively detected using head 
group-specifi c MS/MS scanning modes ( 36, 37 ). The acyl chain 
assembly of the major lipid species was confi rmed by MS/MS 
techniques. The mass spectra were processed by MassLynx soft-
ware (Micromass, Manchester, UK), and the individual lipid 
species were quantifi ed by using the internal standards and 
LIMSA software ( 38 ). The lipid species were abbreviated as 
follows: [total carbon number in the chains]:[total number of 
tryptophan degrading enzyme indoleamine 2,3-dioxygenase, 
and prostaglandin E 2 (PGE 2 ), have been indicated as key 
players in the immunomodulatory process ( 7, 10, 11 ). 
 A long expansion period has been considered to have an 
adverse effect on the proliferation and differentiation po-
tential and other functional properties of progenitor cells 
( 12, 13 ). One of the key questions in MSC therapy is, how 
many cell doublings the cells can undergo before the risks 
of cellular malfunction or even malignant transformation 
surface? The number of safe cell doublings may be depen-
dent on the cell source, donor age, and culture conditions. 
 To date, only a few studies on stem cell membrane lipids 
have been performed ( 13, 14 ), and the changes in lipid 
composition during the expansion have not been studied 
systematically. Although glycosphingolipids and signaling 
lipids have been studied in relation to the cell identity and 
functions ( 15–18 ), an important group of membrane lip-
ids, the glycerophospholipids (GPL), composing the main 
part of membrane lipids has received less attention. The 
most prominent class, phosphatidylcholine (PC), makes up 
approximately one half of all membrane phospholipids. 
Phosphatidylethanolamine (PE), phosphatidylserine (PS), 
and phosphatidylinositol (PI) are the other common 
mammalian GPL classes. Each class consists of numerous 
different molecular species with different acyl, alkyl, or 
alkenyl chain assemblies ( 19 ). Consequently, a single cell 
contains more than a thousand different GPL molecular 
species ( 20, 21 ). However, the ultimate reasons for the 
structural diversity of cellular lipids, apparently of great 
functional importance, are still largely unknown. Modern 
mass spectrometry and bioinformatics tools offer new ways 
to analyze the compositional changes in complex stem cell 
lipidomes and link those with the altered potency and 
quality of the cells ( 22–24 ). 
 Membrane lipids not only form a protective layer around 
the cell but also mediate biological signals through several 
pathways employing G-protein activators, second messen-
gers, and nuclear receptor activators ( 25, 26 ). The signaling 
pathways utilizing phosphorylated PIs (PIP), eicosanoids, 
or sphingolipids are well understood. Cellular mediators, 
such as inositol phosphates, diacylglycerols (DAG), lyso-
phospholipids, ceramides, cleaved fatty acids (FA) [e.g., 
arachidonic acid (AA, 20:4n-6) and docosahexaenoic acid 
(DHA, 22:6n-3)], or their derivatives, are released from 
membrane lipids and play an important role in many phys-
iological processes including the regulation of infl am-
mation. The essential polyunsaturated fatty acid (PUFA) 
20:4n-6 is found primarily at the  sn -2 position of most 
membrane phospholipids. It is a precursor for the synthe-
sis of prostaglandins (PG), tromboxanes, and leukotrienes 
( 27 ), one of which, a specifi c PGE 2 , has been proposed as 
one of the soluble factors mediating the MSC immune 
function ( 7, 28 ) The n-3 PUFAs, especially 22:6n-3, are 
precursors for resolvins, protectins, and maresins which, 
in contrast to 20:4n-6 and most n-6 PUFAs, exert their func-
tions during the resolution phase of infl ammation ( 29 ) 
 The aim of our study was to compare the GPL profi les 
of hBMSCs from young and old donors, study the effects 
of sequential expansion of the cells on these profi les, 
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system (ECL, GE Healthcare). Quantifi cation of band intensities 
were performed using GS 800 densitometer and Quantity One 
software (both from Bio-Rad Laboratories). 
 Microarrays 
 RNA was extracted using Qiagen AllPrep DNA/RNA Mini Kit 
(Qiagen, CA) and a Qiagen supplementary protocol, Purifi cation of 
total RNA containing miRNA from animal cells using the RNAeasy 
Plus Mini Kit, according to the vendor’s instructions. Extracted DNA 
was stored for later use and was not used in this study. 
 Labeled RNAs (800 ng/sample) were hybridized onto Agilent 
SurePrint G3 Human GE 8 × 60 K, and then the slides were 
washed and scanned according to the manufacturer’s recom-
mendations. The raw data fi les (.txt fi les) were imported into R 
version 2.13 software ( 42 ) and preprocessed by the BioConduc-
tor package limma version 3.4.5 ( 43 ). After quality control of the 
data, the median probe intensities were log2-transformed and 
normalized according to the method of the quantiles ( 44 ). The 
probes for the same Entrez Genes or lincRNAs (as of 1 January 
2012) were averaged. 
 A linear model including the AGE*PASSAGE + SUBJECT + DYE 
terms followed by a moderated  t -test was utilized for fi nding the 
differentially expressed genes (log2 fold change > 0.58) in the 
comparisons of interest (nominal  P -value < 0.01). The differen-
tially expressed genes were illustrated with violin plot by using R 
package vioplot with height argument 0.4 and analyzed for signifi -
cant enrichments of GO-BP classes by using R library GOSim 
version 1.2.5 ( 45 ). Enrichments with  P -value < 0.01 were consid-
ered signifi cant. Default parameters were used in the GO analysis. 
 Statistical analysis 
 The data were analyzed in both univariate and multivariate 
ways. In the univariate approach, each GPL species or individual 
FA was analyzed separately and presented in fi gures as mean 
+ SD. Statistical signifi cances for the differences between 
hBMSCs from the young and old donors or early and late pas-
sages were calculated using Student paired  t -test (* P < 0.05, 
** P < 0.01, *** P < 0.001). In addition, the changes in each lipid 
percentage were analyzed with linear mixed-effects models, fi tting 
a model with fi xed terms for age and passage and a random effect 
for cell line (a repeated measures type analysis). The effect of each 
term for every lipid was estimated using normal F-test  P -values and 
visualized with interaction plots depicting the mean values in 
each passage and group. Software for statistical analysis was R 
version 2.12, using package “nlme” for a mixed-effects analysis. 
 In the multivariate approach, the lipidome data were sub-
jected to principal components analysis (PCA) to study differ-
ences between the samples in terms of the whole GPL profi le and 
to fi nd out which GPL species were mainly responsible for the 
variation in the data. PCA was computed using log10 normalized 
data, and the relative positions of the samples and variables were 
plotted using the fi rst two principal components. In addition, 
quantitative multivariate measures of the differences among the 
sample groups were determined by soft independent modeling 
of class analogy (SIMCA) ( 46 ). 
 RESULTS 
 Cultivated hBMSCs reached replicative senescence, and 
the cells from old donors showed larger variation in their 
growth potential 
 hBMSCs isolated from fi ve elderly donors (62–82 years 
of age, mean 74.6 years) and fi ve young adult donors 
double bonds in the chains]. The relative concentrations of the 
lipid classes were obtained by summing the concentrations of 
the individual molecular species in a class. 
 The FAs in the total lipids of the cells were determined as 
methyl ester derivatives by gas chromatography as detailed in 
Käkelä et al. ( 39 ). The FA composition was calculated as molar 
percentage , and the FAs were marked by using the following 
abbreviations: [carbon number]:[number of double bonds] 
n-[position of the fi rst double bond calculated from the methyl 
end] (e.g., 22:6n-3). 
 Co-culture assay 
 Peripheral blood mononuclear cells (PBMC) were isolated 
from buffy coats from healthy anonymous blood donors (Finnish 
Red Cross Blood Service) by density gradient centrifugation (Ficoll-
Pague plus, GE Healthcare, Piscataway, NJ) and cryo-preserved for 
later use. Prior to use, the PBMCs were thawed gently and labeled 
with 5 µM 5(6)-carboxyfl uorescein diacetate N-succinimidyl ester 
(CFSE) solution (Molecular probes, OR). The CFSE-labeled 
PBMCs were cultured in triplicates at 1.5 × 10 6 cells/well in a 
48-well plate with hBMSCs in RPMI growth medium (RPMI, 10% 
FBS, 100 units/ml penicillin, and 100   g/ml streptomycin). hBMSCs 
were allowed to attach for 2 h before PBMCs were added. To acti-
vate the T-cell proliferation, 100 ng/ml of antihuman CD3 anti-
body clone Hit3a (BioLegend, San Diego, CA) was added to the 
coculture. T-cell proliferation was recorded after four days of incu-
bation as a dilution of fl uorescent dye by fl ow cytometry. 
 Telomere length analysis 
 Telomere length were analyzed by the southern blot analysis 
of terminal restriction fragment (TRF) lengths ( 40 ) Genomic 
DNA from snap-frozen cell pellets was purifi ed using the Qiagen 
DNeasy Blood and Tissue Kit and extracted with ethanol. Quality 
of purifi ed DNA was evaluated by 1% agarose gel electrophore-
sis. Telomere length analysis was performed using TeloTAGGG 
Telomere Length Assay Kit (Roche, Basel, Switzerland). DNA was 
digested using  RsaI and  HinfI enzymes and electrophoresed on 
a 0.8% agarose gel 5 V/cm. Southern blotting was performed 
using 20× salium sodium citrate (SSC) buffer. The blot was 
hybridized overnight using a digoxigenin (DIG)-labeled telomere-
specifi c probe (TTAGGG) and incubated with alkaline pho-
sphatase-labeled anti-DIG antibody. The blot was then incubated 
with CDP-Star chemiluminescent substrate and exposed to auto-
radiography fi lm (GE Healthcare). The autoradiogram was 
scanned by densitometry, and TRF length was calculated using 
ImageJ analysis software ( 41 ) according to TRF =   OD/  (OD i /L i ), 
where OD i is optical density and L i is the length of the TRF at 
position i. TRF signals between 3 and 20 kb were used for telom-
ere length measurements ( 40 ). 
 Western blotting 
 Snap-frozen cell pellets were lysed using RIPA buffer (Thermo 
Scientifi c, Rockford, IL) containing protease inhibitor cocktail 
(Sigma, St. Louis, MO). Protein concentrations were determined 
using BCA protein assay kit (Pierce, Rockford, IL). Total protein 
(20 µg) was run on a 12% SDS-PAGE gel (Bio-Rad Laboratories, 
Hercules, CA) and electrotransferred to Hybond ECL Nitrocel-
lulose membrane (GE Healthcare). The membrane was then 
blocked with 5% milk in PBS containing 0.1% Tween-20 and im-
munoblotted using anti-p16 INK4A (1: 800, clone DCS-50, Sigma) 
and anti-p21 (1:250, Clone SXM30, BD Pharmingen).   -actin 
(1: 8000, monoclonal anti-  -actin, clone AC-74, Sigma) was used 
as a loading control. Polyclonal anti-mouse horseradish peroxi-
dase (HRP)-conjugated antibody was used as a secondary anti-
body (1:1000, Dako Cytomation, Glostrup, Denmark). Detection 
was performed using enhanced chemiluminescent detection 
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old donors had very similar class profi les. The GPL spe-
cies of the hBMSCs ( Fig. 2 )  showed that the major PC 
species (in descending order) were 34:1, 36:2, 36:1, and 
38:4 ( Fig. 2A ), whereas the most abundant PE species 
were 38:4, 36:1, 36:2, 40:5, 38:5, and 34:1 ( Fig. 2B ). The 
predominant PS species were 36:1, 40:5, and 40:6 ( Fig. 2C ), 
and a single species, 38:4, accounted for almost 50% of 
the total PI ( Fig. 2D ). In the early-passage samples, statis-
tically signifi cant differences ( P < 0.05) due to the donor 
age were found for PC38:5 and PE38:4 ( Fig. 2A, B ). The 
levels of PE alkenyl and PC alkyl species also changed 
during the long-term passaging ( Table 1 ). 
 Expansion of hBMSCs increases membrane PI content 
in relation to PS 
 During long-term cultivation, PI totals increased, es-
pecially in the cells from young donors ( Table 1 ). This 
increase of PI became even clearer when the PI totals 
were studied in relation to the PS totals. In the hBMSCs 
from the old donors, the PI/PS ratio was already high at 
the earliest passage ( Fig. 3 ).  Interestingly, lysoPC totals 
also increased consistently during cell expansion of the 
hBMSCs from young donors but showed varying re-
sponses in the hBMSC from old donors (supplementary 
Fig. III). 
(20–24 years of age, mean 22.2 years) were characterized 
and shown to fulfi ll the established minimal criteria for 
MSCs ( 47 ) (supplementary Fig. I). At the end of the cell 
culture (45–108 days, depending on the donor), the 
hBMSCs adopted typical senescent morphology (“fried 
egg”) ( Fig. 1A , right).  The proliferation capacity of the 
primary hBMSCs was assessed by determining the cumu-
lative population doublings as cells were passaged until 
senescence. The hBMSCs from old donors showed 
greater individual variation in their growth kinetics than 
those from young donors ( Fig. 1B ). It should be noted 
that the cell doublings before passage 4 were not in-
cluded in the calculations. The replicative senescence 
was further studied from selected samples and passages. 
The replicative senescence enhanced the expression of 
cell-cycle components p16 INK4A and p21 CIP1/WAF1 ( Fig. 1C ). 
Additional proof was obtained from telomere length 
measurements. Telomere length in passage 11 cells was 
1.0 ± 0.5 kbp shorter than that in passage 4 ( Fig. 1D , sup-
plementary Fig. II). 
 GPL profi les of hBMSCs from young and old donors 
 The average values for GPL class totals for hBMSCs 
were PC, 41–46%; PE, 34–38%; PS, 5–8%; and PI, 4–8% 
( Table 1 ).  In general, the hBMSCs from the young and 
Fig. 1. Long-term cell culture of hBMSCs. A: A rep-
resentative example of cell morphology at passage 3 
and in senescence (p14) at a magnifi cation of 40×. B: 
hBMSCs were isolated from the human bone mar-
row of ten donors and cultured until senescence was 
reached. Cumulative population doublings (CPD) 
was calculated in relation to the starting point of the 
cell culture at every passage (F, female; M, male). C: 
Western plot analysis of cell cycle components p16 
and p21 of early and late passages of three different 
hBMSC donors. Fold change (FC) represents the in-
crease of band intensities in late-passage cells com-
pared with early-passage cells. Intensities of the p16 
and p21 bands normalized to -actin are listed on 
the last rows. D: Telomere lengths (TRF, terminal re-
striction factor) were determined in early- and late-
passage cells from three different cell lines. Results 
are show as mean + SD of three technical replicates. 
Telomere lengths were shortened on average 1 kb ± 
0.5 (Student t-test P = 0.03, n = 3). E: Immunosup-
pressive capacity of early and late passages analyzed 
by coculture assay. 5(6)-Carboxyfl uorescein diacetate 
N-succinimidyl ester (CSFE)-labeled peripheral blood 
mononuclear cells (PBMC) were cultured with 
hBMSC in ratio of 1:10 for four days. T-cell prolifera-
tion was stimulated with monoclonal CD3 antibody, 
and proliferation was analyzed as CFSE dilution by 
fl ow cytometry. In the overlay panel, black line indi-
cates no hBMSCs, red line indicates late-passage 
hBMSCs, and blue line indicates early-passage 
hBMSC. X-axis shows the fl uorescence intensity of 
CFSE on a logarithmic scale, and Y-axis shows the cell 
count. Experiment repeated three times with similar 
results using hBMSCs and PBMCs from independent 
donors.
 at Terkko - N
ational Library of Health Sciences, on M
ay 16, 2016
w
w
w
.jlr.org
D
ow
nloaded from
 
.html 
http://www.jlr.org/content/suppl/2012/12/27/jlr.M030650.DC1
Supplemental Material can be found at:
626 Journal of Lipid Research Volume 54, 2013
(34:1 and 36:1) and in those containing n-3 PUFAs (40:5, 
40:6, and 40:7). The most dramatic change was seen in the 
PC and PE diacyl species 38:4. Over all the passages, the 
levels of PC34:1 and PE36:1 species in the hBMSCs from 
the young donors were consistently higher than those 
from the old donors ( Fig. 4C ). These changes were fur-
ther highlighted when multivariate statistical analysis 
(PCA) indicated the 38:4 and 36:4 species of PC and PE 
(with 20:4n-6) as the ones explaining the greatest part of 
the compositional variation among all the studied hBMSCs 
( Fig. 4D ). In the PCA biplot, these 20:4n-6-containing 
 Expansion of hBMSCs increases 20:4n-6-containing 
GPL species at the expense of MUFA and n-3 
PUFA-containing species 
 Expansion of the hBMSCs induced alterations in the 
relative amounts of numerous individual lipid species, as 
revealed by ESI-MS. For instance, in the PC diacyl species, 
the molar percentage of 38:4, 36:4, and 36:1 increased 
toward the latest passages, while the molar percentage 
of 34:1, 34:2, and 36:2 decreased ( Fig. 4A , B ).  The PE diacyl 
species profi les exhibited an increase in 38:4 and 36:4 
species and a decline in the monounsaturated species 
TABLE 1. Molecular percentage of lipid classes determined by ESI-MS
Young Donors Old Donors
Lipid Class Early Passage Late Passage Early Passage Late Passage
PC diacyl 37.3 ± 2.7 37.4 ± 3.4 35.5 ± 2.4 39.0 ± 3.7
PC alkyl 5.8 ± 0.3 5.1 ± 0.4** 5.3 ± 0.5 6.6 ± 0.8*
PE diacyl 20.4 ± 1.1 15.1 ± 2.1* 19.9 ± 3.8 17.2 ± 3.4
PE alkenyl 16.1 ± 2.1 22.7 ± 4.7* 16.8 ± 2.6 16.5 ± 1.9
PI 3.9 ± 1.2 7.7 ± 1.7* 5.4 ± 1.3 8.2 ± 3.4
PS 8.0 ± 4.8 4.9 ± 1.1 5.3 ± 1.1 5.9 ± 2.1
PI/PS 0.5 ± 0.2 1.6 ± 0.4* 1.0 ± 0.1 1.4 ± 0.5
lysoPC 0.5 ± 0.1 1.5 ± 0.9 1.2 ± 0.5 1.2 ± 0.6
The totals for lipid classes were calculated by summing individual lipid species of each class. The statistical 
difference between the young and the old donors was calculated using Student two-tailed t-test (paired). *P < 0.05, 
**P < 0.01.
Fig. 2. Species composition in GPL classes of hBMSCs 
as determined by ESI-MS. The individual lipid spe-
cies were quantifi ed using appropriate internal stan-
dards. The values for GPL species were expressed as 
molar percentage per the total of detected lipids in a 
given class. PC (A), PE (B), PS (C), and PI (D) species 
from passage 4 are shown. Results are the mean + SD 
(n = 5) for both the young (white bars) and old (gray 
bars) donors (*P < 0.05).
 at Terkko - N
ational Library of Health Sciences, on M
ay 16, 2016
w
w
w
.jlr.org
D
ow
nloaded from
 
.html 
http://www.jlr.org/content/suppl/2012/12/27/jlr.M030650.DC1
Supplemental Material can be found at:
Lipidomes of aging mesenchymal stem cells 627
complete when the late-passage hBMSCs were used ( Fig. 1E , 
red line). To further study the correlation between immu-
nosuppressive capacity and the identifi ed lipid or fatty 
acid indicators, we analyzed the GPLs and FAs of hBMSCs 
from eight donors. These cells (from passage 4) had di-
verse functionality. Convincing correlation with the func-
tionality was observed for PC species (38:4, 38:5, 34:1 and 
the ratio of 38:4/34:1) and fatty acids (20:4n-6, 22:6n-3 
and the ratio of the two) ( Table 2 ). 
 Gene expression differences related to donor age 
and cell expansion 
 Next, we made a gene expression analysis of the early-
passage ( 4 ) and late-passage ( 8 ) cells. Measuring the com-
positional distances for the samples from different passages 
by SIMCA showed that, in terms of the GPL profi le, all pas-
sages 4 and 6 samples were statistically signifi cantly different 
from all samples from passages 10 and higher ( P < 0.05). 
As passage 8 represented a time point preceding changes 
in the metabolite profi le, cells from this passage were cho-
sen for the gene expression analysis. Altogether, 707 genes 
were found to be differently expressed between the old 
and young donor samples in passage 4 ( Fig. 6A ).  Interest-
ingly, during expansion, the hBMSCs from the old donors 
showed almost fi ve times more gene expression changes 
(576 genes) than the cells of the young donors (175 genes). 
Only 36 were shared between the young and old donors 
( Fig. 6A ). In addition, the variance in the fold changes was 
the greatest (i.e., 2.3) when comparing the old and young 
donors. The fold change variances due to cell expansion 
were 1.4 for the old donors and 0.7 for the young donors. 
Thus, cell expansion seemed to affect gene expression 
more in the cells of the old donors than in those of the 
young donors ( Fig. 6B ). 
 We further investigated the enrichment of differentially 
expressed genes in different biological processes. In the 
old donors, gene ontologies (GO) relating to lipid metab-
olism and immunological processes as well as differentia-
tion and developmental functions were downregulated 
( Fig. 6C ), whereas GO related to adhesion, signal trans-
duction, and apoptosis were upregulated ( Fig. 6D ). The 
expansion-induced changes (old donors) relating to cell 
division, aging, and apoptosis were upregulated ( Fig. 6E ), 
whereas the downregulated GO terms included sterol 
biosynthetic processes, development, and aging ( Fig. 6F ). 
Results from the young donor group were similar but less 
distinct (supplementary Table VI). 
 As revealed by GO analysis, the expression of several 
genes related to lipid metabolism changed. Both etha-
nolamine kinase 2 and choline kinase   had lower expres-
sion levels in the hBMSCs from the old donors than in 
those from the young donors. Scavenger receptor B1 had 
lower expression level and scavenger receptor B3 (also 
known as  CD36 ) had higher expression level in old donors. 
Interestingly gene expression of phospholipid scramblase 
1 was lower and putative aminophospholipid translocase 
( ATP10A ) was higher in the hBMSCs of the old donors. 
Further, the gene expression of phospholipid scram-
blase 4 was elevated during expansion. Gene expression of 
species had an inverse relationship with the mono- and 
diunsaturated ones. The principal component 1 explained 
up to 52% of the variation among the samples. 
 The FA profi les by GC showed that the proportions of 
individual saturated FAs (SFA), such as 18:0, increased 
toward the late passages, whereas individual monounsatu-
rated FAs (MUFA) decreased ( Fig. 5A ).  Among n-6 PUFAs, 
20:4n-6 increased clearly and constantly throughout the 
expansion along with 20:3n-6, while other principal n-6 
PUFAs decreased ( Fig. 5A , supplementary Fig. IV). At the 
same time, the two prominent n-3 PUFAs, 22:5n-3 and 
22:6n-3, decreased, the response being clearer for 22:6n-3 
( Fig. 5A , supplementary Fig. IV). Consequently, the ratios 
of 20:4n-6 to 22:6n-3 and the total n-6 PUFA to the total 
n-3 PUFA were signifi cantly increased from passage 4 to 
the last passage studied ( Fig. 5A , insert). Thus, the clearest 
fi nding in the PC and PE species profi les, the increases of 
38:4 and 36:4, was supported by the observed clear accu-
mulation of 20:4n-6 in the cellular total FA pool. Com-
pared with the medium in the early-passage samples, 
the relative levels (mol%) of 16:0 and MUFAs (16:1n-7, 
18:1n-7, 18:1n-9) were lower, but those of 18:0 and PUFAs 
(except linoleic acid, 18:2n-6) were higher ( Fig. 5A ). In 
addition to the relative levels, we further studied the total 
amount of FAs in the cells on the culture dish and the 
amount of FAs available for the cells in the surrounding 
medium. The results demonstrated that, in the medium, 
FAs (including the essential PUFAs of the n-6 and n-3 fam-
ilies) were available in excessive amounts compared with 
the cells ( Fig. 5B ). 
 Immunosuppressive capacity of hBMSCs decreases 
during cell expansion and correlates with the 
lipid changes 
 Using a coculture assay, we next studied the ability of 
expanded hBMSCs to suppress T-cell proliferation. The 
early-passage hBMSCs inhibited T-cell proliferation almost 
completely ( Fig. 1E , blue line); the suppression was less 
Fig. 3. The ratio of PI to PS from early to late passages of the 
hBMSC. hBMSCs were cultured from passage 4 to senescence. Cells 
were harvested for GPL analysis from every other passage. The GPL 
species were analyzed after extraction by direct infusion ESI-MS. 
The PI and PS class totals were obtained by summing the amounts 
of individual species in each class, and subsequently the ratio of 
PI to PS was calculated. Young donors, n = 5. Old donors, n = 5.
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Fig. 4. Effect of long-term cell culture on the PC and PE species of hBMSC. hBMSCs were cultured from passage 4 (p4) to senescence. 
Cells were harvested for GPL analysis from every other passage. The GPL species were analyzed after extraction by direct infusion ESI-MS, 
and their values were expressed as molar percentage per the total of detected lipids in a given class. Results are the mean + SD of hBMSCs 
from young (left panel) and old (right panel) donors. Paired Student t-test was performed between the earliest and last passages. (*P < 0.05, 
**P < 0.01). A: PC. B: PE. C: Multivariate PCA using PC and PE data as loadings. For simplicity, the areas covering the positions of the indi-
vidual sample points are shown. D: Mean values of PC34:1, PC38:4, PE36:1, and PE38:4 in both groups over passages.
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1-acylglycerol-3-phosphate-O-acyltransferase 2 and serine 
palmitoyltransferase were elevated during expansion. 
Five genes for FA metabolizing enzymes were differently 
expressed ( Table 3 ).  Among them, the expression levels 
of three FA desaturase genes were lower in the cells of the 
several other putative aminophospholipid translocases 
differed between young and old donors and further dur-
ing expansion (supplementary Tables III–V). Further, 
inositol triphosphate receptor 1 gene expression was ele-
vated during expansion. The gene expression of enzymes 
Fig. 5. Effect of long-term culture on the FA composition of hBMSC. Samples for gas chromatographic FA 
analysis were collected as described in Fig. 4. FAs were analyzed as methyl esters. Results for the cells from 
the earliest and last passages were expressed as mean + SD, n = 10 (*P < 0.05, **P < 0.01, ***P < 0.001). For 
the medium, three replicates were analyzed. A: Molar percentages of FAs from the earliest passage (white 
bar) and the last passage (light-gray bar) compared with those of the medium (dark-gray bar). Insert shows 
the ratios of 20:4n-6 to 22:6n-3 and n-6 PUFAs to n-3 PUFAs in the earliest and last passages compared with 
values of the medium. B: Total amounts (nmol) for each FA in the cells and surrounding culture medium. 
Insert shows the total amounts (nmol) of some PUFA species in enlarged scale.
TABLE 2. Regression analysis of correlation between immunosuppression capacity and the best lipid indicators 
in hBMSCs
Lipid or Fatty Acid Indicator Correlation Coeffi cient R2 P Value Range (mol%)
PC38:4(chains 18:0, 20:4n-6) 0.91 0.84 0.001 4.7–7.7
PC38:5(chains 18:1, 20:4n-6) 0.82 0.68 0.012 4.2–6.3
PC34:1(chains 16:0, 18:1) +0.80 0.64 0.017 23.5–27.0
PC38:4/PC34:1 0.90 0.81 0.003 0.17–0.33
20:4n-6 0.71 0.50 0.050 6.1–9.6
22:6n-3 +0.75 0.56 0.032 2.0–3.3
20:4n-6/22:6n-3 0.76 0.58 0.029 2.2–4.9
The hBMSCs (n = 8, all cultured until passage 4) suppressed T- cell proliferation in a coculture assay (degree 
of inhibition with hBMSC:PBMC ratio 1:20; range, 70–88%) and relative amounts of selected lipid and fatty acid 
indicators or their ratios in the cells.
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Fig. 6. Differential gene expression of hBMSCs. Differentially expressed genes between old and young donor hBMSCs in the earliest 
passage 4 (o4-y4) and between passages 8 and 4 of old (o8-o4) and young (y8-y4) donor hBMSCs were compared. Cut-off values 0.58 (up-
regulated genes) and 0.58 (downregulated genes) were used. A: Venn diagram demonstrating the separate and overlapping genes 
in each group. B: Violin plot combines boxplot with kernel density plot and is used to illustrate fold change variations and the amount 
of differentially expressed genes in the above-mentioned comparisons. C–F: GO enrichment analysis of differentially expressed genes. 
C: Genes with higher expression level in old (o4-y4). D: Genes in which expression decreased during cultivation (o8-o4). E: Genes with 
higher expression level in young (o4-y4). F: Genes in which expression induced during cultivation (o8-o4). The Y axis shows the GO term 
while the X axis shows log10 P-values for the enriched GO terms. For clarity, several GO terms have been excluded based on their simi-
larity. mRNA data are available in GEO database http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE39035 with GEO accession 
number GSE39035.
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less expressed in the old donors; interestingly,  ASB5 
expression was increased during cell expansion ( Table 3 ). 
The expression of the immunologically important COX-1 
gene  PTGS1 was downregulated in the late-passage cells. 
Interestingly, both  TGFBR1 and  IL6 were upregulated 
in the late-passage cells. Other important genes related 
to the immune system, such as bradykinin receptor 1, 
 HLA-DMA ,  HLA–DMB ,  HLA - DRA ,  CD74 , and  LAT2 , were 
less expressed in the early-passage cells of the old donors. 
 During passaging in the hBMSCs of both young and old 
donors, the predominant gene expression changes were 
related to cell cycle, chromatin assembly, and DNA integ-
rity (i.e., histone cluster genes; see supplementary Table II). 
Importantly, of those 36 genes changing during passaging 
in both young and old donors, 12 were histone cluster 
genes ( Fig. 6A ). 
old donors (i.e.,  FADS1 ,  FADS2 ,and  SCD , coding for fatty 
acid   5-,   6-, and   9-desaturases, respectively). LysoPC 
acyl transferase genes  LPCAT2 and  LPCAT3 also had lower 
expression levels in old donors. In addition, the gene pro-
ducing cyclooxygenase 1 enzyme [ COX1 , also known as 
prostaglandin endoperoxide synthase ( PTGS1 )] and gene 
producing prostacyclin receptor ( PTGIR , also known as 
prostaglandin I 2 receptor) were more expressed in pas-
sage 8 compared with passage 4. Finally, leukotriene C4 
synthase and ELOVL fatty acid elongase 3 were expressed 
at lower levels in the cells of the old donors compared 
with those of the young donors. 
 As an indicator for the modulation of immune func-
tions, the genes for the suppressors of cytokine signaling 
( SOCS1 and  SOCS2 ) and several genes from ASB family 
(Ankyrin repeat and SOCS box-containing proteins) were 
TABLE 3. Differentially expressed genes
Mean Fold Change
Description HGNC Gene ID o4-y4 o8-o4
Lipid metabolism
 1-acylglycerol-3-phosphate O-acyltransferase 2 AGPAT2 10555 0.6
 ATPase, class V, type 10A (aminophospholipid 
 translocase)
ATP10A 57194 0.7
 Choline kinase  CHKB 1120 1.2
 CD36 molecule (thrombospondin receptor)] CD36 948 4.4
 ELOVL fatty acid elongase 3 ELOVL3 83401 1.0
 Ethanolamine kinase 2 ETNK2 55224 0.8
 Fatty acid desaturase 1(delta -5–desaturase) FADS1 3992 1.4
 Fatty acid desaturase 2(delta-6-desaturase) FADS2 9415 1.6
 Fat storage-inducing transmembrane protein 2 FITM2 128486 0.7
 Inositol 1,4,5-trisphosphate receptor, type 1 ITPR1 3708 1.0
 Leukotriene C4 synthase LTC4S 4056 1.3
 Lysophosphatidylcholine acyltransferase 2 LPCAT2 54947 2.2
 Lysophosphatidylcholine acyltransferase 3 LPCAT3 10162 0.7
 Phospholipid scramblase 1 PLSCR1 5359 0.9
 Phospholipid scramblase 4 PLSCR4 57088 1.1
 Prostaglandin-endoperoxide synthase 1 PTGS1 5742 0.7
 Prostaglandin I2 (prostacyclin) receptor (IP) PTGIR 5739 0.7
 Scavenger receptor class B, member 1 SCARB1 949 1.9
 Serine palmitoyltransferase, 
 long chain base subunit 3
SPTLC3 55304 0.6
 Stearoyl-CoA desaturase (delta-9-desaturase) SCD 6319 2.4 1.1
Immune response
 Alpha-2-macroglobulin 2 3.8
 Ankyrin repeat and SOCS box containing 2 ASB2 51676 1.2
 Ankyrin repeat and SOCS box containing 5 ASB5 140458 1.0
 Ankyrin repeat and SOCS box containing 10 ASB10 136371 0.9
 Bradykinin receptor B1 BDKRB1 623 3.9
 CD74 molecule, major histocompatibility complex, 
 class II invariant chain
CD74 972 0.7
 Complement component 3a receptor 1 C3AR1 719 1.0
 Interferon (,  and omega) IFNAR2 3455 0.9
 Interleukin 6 IL6 3569 0.7
 Interleukin 26 IL26 55801 1.4
 Linker for activation of T cells family member 2 LAT2 7462 0.9
 Major histocompatibility complex, class II, DM  HLA-DMA 3108 2.0
 Major histocompatibility complex, class II, DM  HLA-DMB 3109 2.0
 Major histocompatibility complex, class II, DR  HLA-DRA 3122 2.1
 Suppressor of cytokine signaling 1 SOCS1 8651 0.6
 Suppressor of cytokine signaling 3 SOCS3 9021 1.0 0.8
 Transforming growth factor,  receptor 1 TGFBR1 7046 1.2
Differentially expressed genes related to lipid metabolism and immune response. o4-y4, comparison between 
old and young donor samples in passage 4; o8-o4, comparison between old donor samples in passages 8 and 4.
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expressed in hBMSCs ( 56 ). Our microarray data con-
fi rmed  PTGS2 expression but did not show statistically sig-
nifi cant differences. Due to the low gene expression levels 
of  LPCAT2 and  3 , the recycling of 20:4n-6 to PC may have 
been impaired in the cells of the old donors, thus strength-
ening the shift to eicosanoid production. The connection 
to eicosanoid production is in line with the previously pro-
posed role of eicosanoids in hMSC immunomodulative 
properties ( 7 ) and further supported by our observation 
that during expansion and simultaneous increment of 
20:4n-6 content, hBMSCs lose part of their capacity to sup-
press T-cell proliferation ( Fig. 1E ). Similarly, we found 
convincing negative correlations between the immuno-
modulatory capacity of hBMSCs from eight donors and 
the relative amounts of 20:4n-6-containing species in PC 
or the relative amount of 20:4n-6 in total FAs of the cells 
( Table 2 ). This encourages for further studies of the im-
munomodulative effector lipids affecting stem cells. 
 The composition of the total PUFA pool available in the 
cells (but not in the medium) ( Fig. 5A, B ) dictated the spe-
cies profi les of membrane phospholipids and may also 
have affected the proportions of different GPL classes in 
the membranes (e.g., the ratio of PI/PS) ( Fig. 3 ). The in-
crease of the PI/PS ratio during expansion may be a direct 
consequence of the change in the cellular PUFA status 
due to the substrate preference in the PS biosynthesis for 
22:6n-3 and in PI synthesis for 20:4n-6 ( 57, 58 ).The change 
in PI and PS levels is biologically highly important as both 
of these anionic GPLs are concentrated on the inner leaf-
lets of membranes where they activate proteins and take 
part in signaling events ( 59 ). Anionic lipids and PIPs act as 
potent activators of cPLA 2 releasing 20:4n-6 and other 
PUFAs ( 60 ). In addition, PI, PIPs, and PS normally func-
tion in concert to target protein kinases, such as PKC, Akt, 
sphingosine kinase, and 3-phosphoinositide-dependent 
kinase-1, to membranes for activation and signaling ( 61–64 ). 
PIP-derived and phospholipase C-liberated DAG and PS 
activate the PKC, but their roles are different. Even 
small concentrations of DAG turn PKC on, but full enzy-
matic activity is achieved by PS ( 65 ). Thus, changes in the 
ratio of PI/PS may have profound effects on hBMSC ther-
apeutic functions via the regulation of the activities of 
kinases, phospholipases, and/or other proteins. We also 
emphasize that PIPs regulate the scavenger receptor B1 
(SR-B1) of lipoprotein traffi cking ( 66 ), and in our study, 
SR-B1 was expressed at a higher level in the hBMSCs of the 
young donors. Interestingly, we found that gene expres-
sion of several ATPases was altered.  ATP10A , one of the 
putative aminophospholipid translocases, and bidirec-
tional phospholipid translocator scramblase 1 were ex-
pressed at higher levels in the hBMSCs of the old donors. 
Furthermore, the gene expression of scramblase 4 was 
increased during expansion ( 67, 68 ) Thus our data indi-
cate physiologically important GPL remodeling with func-
tional consequences in the hBMSCs. 
 In resting cells, the amount of free PUFAs is strictly reg-
ulated by lysophospholipid acyltransferases that recycle 
most of the cleaved PUFAs back to the membrane GPLs. 
Only a small fraction of PUFAs is used for the synthesis of 
 DISCUSSION 
 This study focused on the membrane GPL and total FA 
composition of hBMSCs. The role of the donor’s age, indi-
vidual variation, cell expansion, and FA composition of 
the surrounding medium were taken into account. Since 
no previous studies on MSC phospholipid profi les have 
been reported, we compared our results on the lipid pro-
fi les of hBMSCs with the previously published profi les 
of functionally very similar human primary fi broblasts 
( 21, 48 ). Our study demonstrates that at the lipid class 
level ( Table 1 ), the relative amounts of PC, PS, and PI of 
the hBMSCs were almost identical to that described for 
human fi broblasts. However, the relative amount of PE 
was much higher in the hBMSCs than was the amount 
reported for fi broblasts ( 21 ) or mammalian cells on aver-
age ( 49 ). The predominant PE species of the hBMSCs was 
38:4 (18:0/20:4n-6), whereas in human fi broblasts, PE spe-
cies 36:1, 38:4, and 36:2 were present in equal amounts 
( 21 ). This implies that biosynthetic or remodeling path-
ways of the GPLs in these two cell types have differences. 
These differences can be due to altered activities of CoA-
independent transacylase (CoA-IT), which in immuno-
logically activated cells promotes transfer of 20:4n-6 from 
PC to PE, from which different PLA 2 readily release 20:4n-6 
to be used for production of lipid mediators ( 50, 51 ). In 
addition, the higher expression level of the PE biosyn-
thetic enzyme ethanolamine kinase 2, found in the cells of 
the young donors ( Table 3 ), may be linked to an increase 
in the relative amounts of PE ether lipids ( Table 1 ). 
 Expansion caused further enrichment of 20:4n-6-con-
taining PC and PE species (38:4 and 36:4), which hap-
pened at the expense of n-3 PUFA-containing species 
(40:5, 40:6, and 40:7) and short-chain saturated and mono-
unsaturated species of PC and PE ( Fig. 4A, B ). It is possible 
that this increase in the ratio of GPL species with n-6 PUFA 
to those with n-3 PUFA had consequences for the func-
tionality of the cells (i.e., their responsiveness to infl am-
matory signals and capability for immunomodulation) 
( 52 ). If cleaved by activated phospholipases, the different 
PUFAs give rise to signaling molecules with different, even 
opposing functional consequences ( 53, 54 ). This hypoth-
esis was supported by the results obtained from the T-cell 
suppression assay in which we clearly showed that the 
cells lose part of their immunosuppressive potential when 
expanded ( Fig. 1E ). 
 The analysis of FA composition confi rmed the central 
feature that aging hBMSCs gained 20:4n-6 and lost 22:6n-3 
and other n-3 PUFAs. The 20:4n-6 is a precursor for sev-
eral pro- and also anti-infl ammatory molecules, such as 
PGs [cyclooxygenase (COX) pathway] or lipoxins [lipoxy-
genase (LOX) pathway] ( 29 ). Because the rate of COX 
catalyzed synthesis of PGs is known to be affected by the 
local availability of 20:4n-6 and as the expression level of 
the COX-1 gene ( PTGS1 ) was elevated in the passage 
8 samples, it is plausible that the production of 20:4n-6-
derived proinfl ammatory eicosanoids is facilitated in ag-
ing cells ( 55 ). As described earlier by others, the inducible 
form of cyclooxygenase, COX-2 gene ( PTGS2 ), is highly 
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pathways produce different end-product eicosanoids with 
completely different, even opposing, biological functions 
( 55 ). The PUFA alterations reported here ( Figs. 4 and 5 ) 
presumably affect the composition of end products in-
volved in activation or resolution of infl ammation, linked 
to the changes in T-cell suppression capacity ( Fig. 1E ). 
Thus, our results will serve as a basis for further studies 
aiming to understand the lipidomic aspects of the MSC 
immunosuppression. 
 This study is the fi rst to show major changes in phos-
pholipid profi les and total FAs during expansion and 
senescence of therapeutically important hBMSCs. We 
demonstrate that the 20:4n-6 contents of cellular lipids 
increased while the n-3 PUFA contents decreased during 
long-term cultivation. The gene expression differences 
were most notable between the early-passage cells from 
the old and the young donors and supported our lipid 
fi ndings. Our results suggest that the free PUFAs derived 
from membrane lipids are of high importance in hBMSC 
immunological functionality. Because PUFA-derived sig-
naling lipids are known to be involved in MSC functional-
ity but are extremely challenging to use as biomarkers, 
biosynthetic precursors in membranes could be used in-
stead as indicators of cell functionality. In combination 
with additional markers, such as mRNA of lipid enzymes 
and/or other functional factors, membrane lipids can 
serve as powerful new biomarkers for the functionality of 
therapeutic cells.  
 The authors thank Birgitta Rantala and Lotta Sankkila for 
excellent technical assistance and Tanja Kaartinen for advice in 
T-cell proliferation assay. 
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the eicosanoids and other signaling molecules ( 69, 70 ). 
However, the stimulation of the cells results in the activa-
tion of cPLA 2 , and due to the high rates of PUFA libera-
tion, the shift to the production of the signaling molecules 
with biological activity is enforced ( 71 ). The increased 
concentrations of lysoPC, detected especially in the late-
passage hBMSC samples of the young donors, are likely to 
refl ect enhanced PLA 2 activity (several forms of the en-
zyme may be activated) and represent the pool of acceptor 
lysophospholipids ( 72, 73 ), thus giving lysophospholipid 
acyltransferases a role in the regulation of infl ammation 
( 74 ). In this respect, the hBMSCs from the young and the 
old donors had different metabolism: lysoPC acyltrans-
ferases had higher expression levels and lysoPC totals 
also increased during expansion more noticeably in the 
hBMSCs of the young donors compared with the old do-
nors (supplementary Fig. III). Additionally, lysoPC con-
tributes to cellular signaling by activating G-protein-coupled 
receptors, ERK and MAPK signaling, and phospholipase C 
( 75–77 ). The latter releases DAG and inositol triphosphate 
with the liberation of intracellular Ca 2+ and activation of 
PKC. The COX enzymes reside in endoplasmic reticulum 
close to cPLA 2 and are likely to convert mobilized 20:4n-6 
and other PUFAs into eicosanoids ( 54 ). Consequently, less 
free FAs may have been recycled to PC by the lysoPC acyl-
transferase, which could then be observed as the lysoPC 
acceptor accumulation. 
 If the relative increase of 20:4n-6-containing GPLs of 
the hBMSCs have functional consequences, we can assume 
that the simultaneous decrease of n-3 PUFA content is of 
immunological importance as well. Recently, the so-called 
traditional eicosanoids have been found to be accompa-
nied by resolvins, protectins, and maresins, which are 
derivatives of 22:6n-3 and 20:5n-3 and play a role in the 
resolution phase of the infl ammation ( 29 ).The enzymes 
COX and LOX synthesize from the n-3 PUFA counterparts 
to the n-6 PUFA-derived eicosanoids, which, however, have 
mainly anti-infl ammatory properties ( 78 ). In T-cells, the 
n-3 PUFAs have been found to suppress immune functions 
by modulating interleukin-2 expression and exerting their 
effects via PKC isoforms and nuclear factor pathways ( 79 ). 
Thus, the shift from a more balanced n-6/n-3 PUFA ratio 
toward the dominance of n-6 PUFAs found in the total 
FA pool of the aging hBMSCs may have altered the lipid 
signaling pathways from an anti- to proinfl ammatory 
direction ( Fig. 5 ). Due to the constant excess amount of 
FAs in the surrounding medium compared with the cells 
( Fig. 5B ), we can assume that the observed changes in 
hBMSC lipidome were due to an active process of the rep-
licative senescence verifi ed by several different markers 
( Fig. 1A–D ). However, it is possible that supplementing 
the culture medium with even more n-3 PUFAs than pres-
ent in standard growth medium might support hBMSCs 
growth and maintain their physiological functionality for 
longer without manifestations of senescence. Indeed, it 
is fascinating and important to highlight that different 
GPL/FA compositions may cause the hBMSCs to respond 
very differently to the same external stimuli and that, de-
pending on the GPL/FA substrate, the same enzymatic 
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